Product Program year 2019 Source: CMS Open Payments

Prosigna Assay

Device Oncology

Open in the dashboard

General payments

$622,540

67 payments

Research payments

$0

0 payments

Through program year 2019, $622,540 in general payments and $0 in research payments were reported against Prosigna Assay (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $622,540 67

Breakdown

Who paid General payments · program year 2019
  1. NanoString Technologies, Inc. $622,540 67 payments
Top recipients General payments · program year 2019
  1. Matthew Ellis Medical Oncology · Houston, TX $267,243 43% · 6 payments
  2. Philip Bernard Anatomic Pathology & Clinical Pathology · Salt Lake City, UT $267,243 43% · 6 payments
  3. U Of U Hospitals & Clinics Teaching hospital · UT $32,628 5% · 6 payments
  4. Carolinas Medical Center Teaching hospital · NC $32,628 5% · 6 payments
  5. Douglas Kingma Hematology · Franklin, TN $16,878 3% · 13 payments

The top 5 of 17 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Medical Oncology Internal Medicine $272,509 49% · 10 practitioners
  2. Anatomic Pathology & Clinical Pathology Pathology $267,279 48% · 2 practitioners
  3. Hematology Pathology $16,878 3% · 1 practitioner
  4. Hematology & Oncology Internal Medicine $617 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Utah $299,871 48% · 2 recipients
  2. Texas $267,743 43% · 2 recipients
  3. North Carolina $32,628 5% · 1 recipient
  4. Tennessee $16,878 3% · 1 recipient
  5. New York $3,186 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

67 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record